Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis

NCT00441961 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2011-08-11

No results posted yet for this study

Summary

Evaluate the effect of high dose MTX on skin induration in patients with eosinophilic fascia.

Conditions

  • Fasciitis

Interventions

DRUG

methotrexate

methotrexate

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • H. Knaapen, MD · Radboud University Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2010-12-31
Completion
2011-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00441961 on ClinicalTrials.gov